News

Camurus AB: CHMP recommends approval of Oczyesa for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...
CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of ...